Graves’ disease (GD) is the most common cause of hyperthyroidism in developed Countries. It is more common between 30 and 60 years; 5–10 times more frequent in women. The genetic predisposition accounts for 79% of the risk for GD, while environmental factors for 21%. About 70% of genes associated with autoimmune thyroid disorders (AITD) are implicated in T-cell function. Among GD endogenous factors, estrogens, X-inactivation and microchimerism are important. Among environmental risk factors, smoking, iodine excess, selenium and vitamin D deficiency, and the occupational exposure to Agent Orange have been associated with GD. Many studies showed that HCV is associated with thyroid autoimmunity and hypothyroidism, in patients with chronic HCV hepatitis (CHC); a significant link has been shown also between HCV-related mixed cryoglobulinemia and risk for GD. Moreover, IFN-α-treated CHC patients develop GD more frequently. Novel studies are needed about possible risk factors to reduce the occurence of GD in West Countries.
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
Antonelli A.;Ferrari S. M.;Ragusa F.;Elia G.;Cristaudo A.;Foddis R.;Fallahi P.
2020-01-01
Abstract
Graves’ disease (GD) is the most common cause of hyperthyroidism in developed Countries. It is more common between 30 and 60 years; 5–10 times more frequent in women. The genetic predisposition accounts for 79% of the risk for GD, while environmental factors for 21%. About 70% of genes associated with autoimmune thyroid disorders (AITD) are implicated in T-cell function. Among GD endogenous factors, estrogens, X-inactivation and microchimerism are important. Among environmental risk factors, smoking, iodine excess, selenium and vitamin D deficiency, and the occupational exposure to Agent Orange have been associated with GD. Many studies showed that HCV is associated with thyroid autoimmunity and hypothyroidism, in patients with chronic HCV hepatitis (CHC); a significant link has been shown also between HCV-related mixed cryoglobulinemia and risk for GD. Moreover, IFN-α-treated CHC patients develop GD more frequently. Novel studies are needed about possible risk factors to reduce the occurence of GD in West Countries.File | Dimensione | Formato | |
---|---|---|---|
Best Pract Res Clin Endocr Metab 2020 Epidemiology.pdf
non disponibili
Tipologia:
Versione finale editoriale
Licenza:
NON PUBBLICO - accesso privato/ristretto
Dimensione
410.79 kB
Formato
Adobe PDF
|
410.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Best Pract Res Clin Endocr Metab 2020 Epidemiology.pdf
Open Access dal 01/02/2021
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
324.45 kB
Formato
Adobe PDF
|
324.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.